The Benefits of Using Anti-Idiotype Antibodies for CAR Detection in CAR T Therapy
Fang Li2024-11-25T15:29:55+00:00Chimeric Antig en Receptor T-cell (CAR T) therapy has [...]
Accurate Detection of anti-CD19 CAR-T Cells
ken2024-01-19T19:55:46+00:00Application of R19M, An FMC63 scFv Idiotype Monoclonal Antibody Anti-CD19 [...]
Is CD3ζ alone in CAR structure good enough?
ken2024-01-19T19:46:57+00:00Two CD19-specific CARs approved by US FDA in 2017 have [...]
Team up: CAR T meets Immune Checkpoint Inhibitor
ken2024-01-19T19:55:02+00:00Immune checkpoint inhibitor was undoubtedly a breakthrough in cancer therapy. [...]
Umoja – Swahili language, Biotech language
ken2024-01-19T19:34:46+00:00Adaptor CAR platform advances It almost feels like a Christmas [...]
Monitoring anti-CD19 chimeric antigen receptor T cell population by flow cytometry and its consistency with digital droplet polymerase chain reaction
ken2024-01-19T19:55:23+00:00Congratulations on professor Zhu’s new paper on Cytometry. We are [...]
